Khalid Ibrahim, D., دعاء, Akram Yahya, N., & نورالهدى. (2023). Effects of Epigallocatechin-3-Gallate (EGCG) in Diabetes Mellitus as a DYRK1A inhibitor. Iraqi Journal of Pharmacy, 20(2), 168–173. Retrieved from https://rjps.uomosul.edu.iq/index.php/iphr/article/view/21449